169 related articles for article (PubMed ID: 11141229)
1. Results of a clinical trial of clinafloxacin versus imipenem/cilastatin for intraabdominal infections.
Solomkin JS; Wilson SE; Christou NV; Rotstein OD; Dellinger EP; Bennion RS; Pak R; Tack K
Ann Surg; 2001 Jan; 233(1):79-87. PubMed ID: 11141229
[TBL] [Abstract][Full Text] [Related]
2. Trovafloxacin in the treatment of intra-abdominal infections: results of a double-blind, multicenter comparison with imipenem/cilastatin. Trovafloxacin Surgical Group.
Donahue PE; Smith DL; Yellin AE; Mintz SJ; Bur F; Luke DR
Am J Surg; 1998 Dec; 176(6A Suppl):53S-61S. PubMed ID: 9935258
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections.
Walters DJ; Solomkin JS; Paladino JA
Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):551-61. PubMed ID: 10662480
[TBL] [Abstract][Full Text] [Related]
4. Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.
Colardyn F; Faulkner KL
J Antimicrob Chemother; 1996 Sep; 38(3):523-37. PubMed ID: 8889726
[TBL] [Abstract][Full Text] [Related]
5. Imipenem/cilastatin (1.5 g daily) versus meropenem (3.0 g daily) in patients with intra-abdominal infections: results of a prospective, randomized, multicentre trial.
Basoli A; Meli EZ; Mazzocchi P; Speranza V
Scand J Infect Dis; 1997; 29(5):503-8. PubMed ID: 9435041
[TBL] [Abstract][Full Text] [Related]
6. Monobactams and carbapenems for treatment of intraabdominal infections.
Brismar B; Nord CE
Infection; 1999; 27(2):136-47. PubMed ID: 10219648
[TBL] [Abstract][Full Text] [Related]
7. Meropenem versus imipenem/cilastatin as empirical monotherapy for serious bacterial infections in the intensive care unit.
Verwaest C;
Clin Microbiol Infect; 2000 Jun; 6(6):294-302. PubMed ID: 11168137
[TBL] [Abstract][Full Text] [Related]
8. Biapenem versus imipenem/cilastatin in the treatment of complicated intra-abdominal infections: report from a Swedish Study Group.
Brismar B; Akerlund JE; Sjöstedt S; Johansson C; Törnqvist A; Bäckstrand B; Bång H; Andåker L; Gustafsson PO; Darle N; Angerås M; Falk A; Tunevall G; Kasholm-Tengve B; Skau T; Nyström PO; Gasslander T; Hagelbäck A; Olsson-Liljequist B; Eklund AE; Nord CE
Scand J Infect Dis; 1996; 28(5):507-12. PubMed ID: 8953683
[TBL] [Abstract][Full Text] [Related]
9. [Meropenem (Merrem) vs imipenem/cilastatin in hospital treatment of intra-abdominal infections. A multicenter study].
Tonelli F
Minerva Chir; 1997 Mar; 52(3):317-26. PubMed ID: 9148225
[TBL] [Abstract][Full Text] [Related]
10. A multicenter comparative study of meropenem and imipenem/cilastatin in the treatment of complicated urinary tract infections in hospitalized patients.
Cox CE; Holloway WJ; Geckler RW
Clin Infect Dis; 1995 Jul; 21(1):86-92. PubMed ID: 7578765
[TBL] [Abstract][Full Text] [Related]
11. Randomized, double-blind, multicenter trial comparing clinafloxacin with imipenem as empirical monotherapy for febrile granulocytopenic patients.
Winston DJ; Lazarus HM; Beveridge RA; Hathorn JW; Gucalp R; Ramphal R; Chow AW; Ho WG; Horn R; Feld R; Louie TJ; Territo MC; Blumer JL; Tack KJ
Clin Infect Dis; 2001 Feb; 32(3):381-90. PubMed ID: 11170945
[TBL] [Abstract][Full Text] [Related]
12. A post hoc subgroup analysis of meropenem versus imipenem/cilastatin in a multicenter, double-blind, randomized study of complicated skin and skin-structure infections in patients with diabetes mellitus.
Embil JM; Soto NE; Melnick DA
Clin Ther; 2006 Aug; 28(8):1164-1174. PubMed ID: 16982293
[TBL] [Abstract][Full Text] [Related]
13. Cost-minimization analysis of piperacillin/tazobactam versus imipenem/cilastatin for the treatment of serious infections: a Canadian hospital perspective.
Marra FO; Frighetto LO; Marra CA; Sleigh KM; Stiver HG; Bryce EA; Reynolds RP; Jewesson PJ
Ann Pharmacother; 1999 Feb; 33(2):156-62. PubMed ID: 10084409
[TBL] [Abstract][Full Text] [Related]
14. Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study.
Zanetti G; Bally F; Greub G; Garbino J; Kinge T; Lew D; Romand JA; Bille J; Aymon D; Stratchounski L; Krawczyk L; Rubinstein E; Schaller MD; Chiolero R; Glauser MP; Cometta A;
Antimicrob Agents Chemother; 2003 Nov; 47(11):3442-7. PubMed ID: 14576100
[TBL] [Abstract][Full Text] [Related]
15. Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group.
Solomkin JS; Reinhart HH; Dellinger EP; Bohnen JM; Rotstein OD; Vogel SB; Simms HH; Hill CS; Bjornson HS; Haverstock DC; Coulter HO; Echols RM
Ann Surg; 1996 Mar; 223(3):303-15. PubMed ID: 8604912
[TBL] [Abstract][Full Text] [Related]
16. Meropenem versus imipenem-cilastatin for the treatment of hospitalized patients with complicated skin and skin structure infections: results of a multicenter, randomized, double-blind comparative study.
Fabian TC; File TM; Embil JM; Krige JE; Klein S; Rose A; Melnick D; Soto NE
Surg Infect (Larchmt); 2005; 6(3):269-82. PubMed ID: 16201937
[TBL] [Abstract][Full Text] [Related]
17. Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial.
Geddes A; Thaler M; Schonwald S; Härkönen M; Jacobs F; Nowotny I
J Antimicrob Chemother; 1999 Dec; 44(6):799-810. PubMed ID: 10590282
[TBL] [Abstract][Full Text] [Related]
18. Systematic review comparing meropenem with imipenem plus cilastatin in the treatment of severe infections.
Edwards SJ; Emmas CE; Campbell HE
Curr Med Res Opin; 2005 May; 21(5):785-94. PubMed ID: 15969878
[TBL] [Abstract][Full Text] [Related]
19. An open, randomised, multi-centre study comparing the safety and efficacy of sitafloxacin and imipenem/cilastatin in the intravenous treatment of hospitalised patients with pneumonia.
Feldman C; White H; O'Grady J; Flitcroft A; Briggs A; Richards G
Int J Antimicrob Agents; 2001 Mar; 17(3):177-88. PubMed ID: 11282262
[TBL] [Abstract][Full Text] [Related]
20. Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin.
Torres A; Bauer TT; León-Gil C; Castillo F; Alvarez-Lerma F; Martínez-Pellús A; Leal-Noval SR; Nadal P; Palomar M; Blanquer J; Ros F
Thorax; 2000 Dec; 55(12):1033-9. PubMed ID: 11083889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
